Webinar

3D Bioprinting Cancer

Cancer, what a modern-day existential threat to humanity, is a word that triggers a cringe from the most fearless. Over the past decades in modern medicine, we have made much progress in cancer care, ranging from diagnosis, surgical advancements, to therapeutics. Despite that, cancer is surpassing heart diseases as a leading cause of death in the United States in 2020. [Ref] The demand for faster diagnostics and better treatment is driving researchers to technologies like 3D printing and 3D bioprinting. 

Speakers:

Dr. Antti Arjonen

blank

Cancer research, microscopy, cell biology, image-based high-throughput screening, 3D bioprinting

Dr. Karolina Valente

blank

Karolina has a B.Sc. and M.Sc. in Chemical Engineering, and a Ph.D. in Mechanical Engineering. She has deep expertise in tissue engineering, 3D bioprinting, and oncology. Karolina has published multiple peer-reviewed papers and is currently an Assistant Teaching Professor at the University of Victoria and the CEO & CSO of VoxCell BioInnovation.

Raphael Lichtnecker

blank

I got my Master´s degree in Pharmaceutical Bioprocess Engineering at Technical University Munich. Afterwards I started as Business Development Manager at ViscoTec where I am responsible for the technology transfer of the progressive cavity pump to the bioprinting sector. I´m in this position for four years now.

Moderator:

Dr. Jenny Chen

jenny chen

Dr. Jenny Chen is trained as a neuroradiologist, founder/CEO of 3DHEALS. Her main interests include next generation education, 3D printing in the healthcare sector, automated biology, artificial intelligence. She is an angel investor who invests in Pitch3D companies.

blank

3D Printed Prosthetics

Over the years, the images of disabled children with colorful prosthetic limbs inspired impactful movements like the ENABLE community and Victoria Hand Project, as well as enumerable passionate innovators who have pushed the boundaries to increase accessibility and lower the cost of orthotics and prosthetics. However, the field of 3D printed prosthetics has advanced significantly since the days of ENABLE hands. These advancements include not just hardware, materials, but also software, designs, 3D scanning, and lately completely digitalized workflow at the point of care, often leveraging machine learning and artificial intelligence. More importantly, technologists are now working more closely with clinicians to create a more efficient and more evidence-based patient-centered clinical solution. In this highly anticipated webinar, we invited experts with decades of technical, business, and clinical experiences and diverse perspectives to give the attendees a 360-degree view of the current and future status of the industry. 

Speakers:

Bryan Craft

blank

Bryan Craft started his career in medical 3D technology during a time where Coronavirus was threatening the supply of critical medical equipment (PPE). Working with a service bureau in North Carolina, he and his team 3D printed and delivered thousands of face shields to medical professionals in North Carolina and beyond. Bryan has devoted his time to learn how the 3D technology industry can improve medical device manufacturing specifically for Orthotics and Prosthetics. In 2021, Bryan joined the medical technology company, Spentys, where he is making 3D technology a reality in O&P. His core focus is to enhance the patient experience by increasing customization, exploring advanced materials, and working closely with innovative clinicians. Bryan has investigated the time savings for clinicians who adopt streamlined 3D technology and continues to search for new applications and use cases.

Albert Shih

blank

Albert Shih is Professor in Mechanical Engineering, Biomedical Engineering, and Institute of Gerontology at the University of Michigan. He received PhD from Purdue University in 1991 and was a manufacturing engineer at Cummins and an Associate Professor at NC State University before joining the University of Michigan in 2003. He served in the Advanced Manufacturing National Program Office in 2017 and was the President of NAMRI SME in 2019-2020. Dr. Shih is a pioneer in biomedical manufacturing. He is the recipient of the Fulbright Scholar, SAE Teetor Educational Award, SME Taylor Research Medal and Education Award, and ASME Shaw Manufacturing Research, Blackall Machine Tool & Gage Award, and Ennor Manufacturing Technology Award. Professor Shih is the Fellow of ASME, SME, and CIRP.

Michael Peirone

blank

Michael started volunteering with Victoria Hand Project when it was still a university research project, and has seen it grow across the world. Through his years with VHP, Michael has gotten a broad view of the organization as a volunteer, student intern, Biomedical Designer, the COO, and most recently taking on the role of CEO.

Samer Moussa

blank

Samer Moussa has a background that merges design, clinical care, and business development of medical devices. With an undergrad in Mechanical Engineering, a Masters of Science in Orthotics and Prosthetics and currently pursuing an MBA, he has transitioned from everyday clinical care as a CPO to working as a product manager with different medical device manufacturers. From adjustable prosthetic sockets with LIM Innovations to innovative off-the-shelf knee and spine devices with Breg and the latest venture with HP, Arize Orthotics which is a fully developed end-to-end solution for custom orthotics. Samer has been in the O&P industry for 10 years and his main passion is finding the right bridge between new technology and clinical pain points in a way that both businesses can strive.

Prof. Dr. Hans-Werner Schmidt

blank

Hans-Werner Schmidt studied Chemistry at the University of Mainz (Germany) and ETH Zürich (Switzerland). He received his Dr. rer. nat. degree in Macromolecular Chemistry at the University of Mainz. After a stay at the DuPont Central Research in Wilmington, Delaware he moved to the University of Marburg to obtain his Habilitation. From 1989 to 1994 he was Assistant and Associate Professor of Materials with tenure at the Materials Department, College of Engineering at the University of California, Santa Barbara. Since 1994 he is Full Professor for Macromolecular Chemistry at the University of Bayreuth. He was Vice President for research at the University of Bayreuth and is founding director of the Bavarian Polymer Institute. He has many years of research experience in the development of polymer materials for emerging technologies. For over 10 years, he has been involved in the development of materials for additive manufacturing. As co-founder of the German based company PPprint, he is actively involved in the development of 3D printing materials for applications in medical technology.

Moderator:

Dr. Jenny Chen

blank

Dr. Jenny Chen is trained as a neuroradiologist, and founder/CEO of 3DHEALS. Her main interests include next-generation education, 3D printing in the healthcare sector, automated biology, and artificial intelligence. She is an angel investor who invests in Pitch3D companies.

blank

3D Bioprinting for Skin

Skin and its derivatives of hair follicles, nails, sweat, and oil glands play a myriad of important roles within our body. Since the skin comes into direct contact with the outside world, it is highly susceptible to cuts, abrasions, and burns. Although the skin has a higher regenerative capacity than most tissues, the repair of large-scale deep injuries, such as deep burns, is mainly scar repair. The current standard of care for patients with severe large area skin defects consists of autologous skin grafting or dermal substitutes. However, the shortage of donor skin sites and infection risks limit the application of grafts and emerging dermal substitutes still face challenges in delivering cells to clinically relevant wound topologies and the promotion of vascularization. The 3D bioprinting of skin models has garnered increasing research interest in recent years due to the potential in disease modeling, testing the efficacy of new treatments, and providing alternatives to animal testing. Continued developments in 3D bioprinting skin equivalents show promise in defining the composition of biomaterials, cells, and bioactive factors for accelerated wound regeneration.

Speakers:

Abbas Shafiee

blank

Dr Abbas Shafiee is a tissue engineering & regenerative medicine scientist interested in translational cell-based and tissue engineering strategies to treat human diseases. 

Dr Shafiee completed his PhD at The University of Queensland on stem cell biology. His research career during his PhD had key contributions to delineating endothelial niche and vascular stem cells in the human placental tissues, including the seminal discovery of an entirely new stem cell population, coined as ‘Meso-Endothelial Bipotent Progenitor’ and the identification of key driver signatures for endothelial and bipotential progenitor function. Post-PhD, he joined Queensland University of Technology and conducted multiple projects on cancer and bone tissue engineering. Dr Shafiee has developed innovative tissue engineered models intersecting concepts from stem cell biology, cancer, and tissue engineering to study species-specific cancer bone metastasis at an unprecedented level of detail. Utilizing the tissue engineering concept, he was able to better understand the mechanisms of cancer bone metastasis. Additionally, he was successful in obtaining project grants, and developed a biomimetically designed scaffolds and investigated the interactions of multipotent mesenchymal stem/stromal cell and skin progenitors with 3D printed scaffolds. 

Dr Shafiee joined Herston Biofabrication Institute (HBI, MNHHS, Brisbane) in 2020 and started a research program to develop, implement, and evaluate the applications of 3D printing, scanning, cell therapies, and biofabrication technologies in skin wound settings. Using 3D printing and stem/progenitor cell delivery he could develop new approaches to enhances physiological wound closure with reduced scar tissue formation. He is also is part of a national program aiming to develop 3D bioprinting technology to treat skin wounds.

Colin McGuckin

blank

Colin was the UK’s first Full Professor of Regenerative Medicine, before Founding CTIBIOTECH to create not only organ-based models for drug screening and efficacy testing, but also to create cell and organ therapies of the future. Coming from a background of Hematology / Oncology his work expanded in the 1990’s to stem cells and his academic group were first in the world to create neural and hepatic tissues from adult stem cells. Now at CTIBIOTECH they are leaders in 3D bioprinting models of the human body, with a lot of success in complex skin, tumors and liver systems.

Axel Guenther

Professor, University of Toronto

blank

Dr. Guenther is a Full Professor in the Department of Mechanical and Industrial Engineering, with cross-appointment at the Institute of Biomedical Engineering at the University of Toronto. He obtained his doctoral degree from ETH Zurich and conducted postdoctoral research at the Massachusetts Institute of Technology. He received the ETH medal (2002), the Ontario Early Researcher Award (2009), the I.W. Smith Award of the Canadian Society of Mechanical Engineers (2010) and the Innovator of the Year (2013) and Safwat Zaky Research Leader (2021) Awards of the University of Toronto. He is interested in microfluidic and biofabrication strategies for hierarchical biomaterials and tissues. He invented several bioprinting technologies and currently serves as the founding Co-Director of the nationally unique Centre for Research and Applications in Fluidic Technologies (CRAFT), a collaborative research center between the University of Toronto and the National Research Council of Canada (NRC) that aims to accelerate the translation of microfluidic device innovations to industry and to the clinic.

Amaris Castanon

Field Application Specialist at CELLINK

Amaris Castanon

Amaris Castanon completed a Bachelor of Science at the University of Texas at El Paso (UTEP) in Cellular and Molecular Biochemistry and graduated with Magna Cum Laude high honors. She then completed a Master of Science with High Honors in Stem Cell and Regenerative Medicine at The University of Sheffield in the UK, while working at the Kroto Research Institute on a bioengineering project involving regenerative medicine approaches for peripheral nerve injury repair. Amaris has a strong international background having also completed studies abroad at Graz University of Technology in Austria, where she was enrolled in graduate bioengineering courses and discovered her strong passion for regenerative medicine. She has conducted an extensive amount of international research at institutions like University of Pennsylvania (UPENN), University of Texas Medical Branch (UTMB), Universidad Autonoma de Mexico (UNAM), Graz University of Technology (TU Graz), Fraunhofer Institute of Applied Optics and Precision and Engineering in Jena, University of Barcelona, and Kroto Research Institute. Her diverse background has allowed her to obtain significant experience in many research fields including those of stem cell culture, biomaterials, and biochemistry –all fields vital to the interfaced environment that 3D bioprinting faces today. Today, Amaris is a Field Application Specialist working with the Bioprinting team at CELLINK and is proud to form part of the BICO family, committed to revolutionize medicine through bioconvergence.

Dr. Fabien Guillemot

CEO and Founder of Poietis

Dr. Fabien GUILLEMOT

Dr. Fabien GUILLEMOT is a scientist-turned-entrepreneur, CEO and Founder of Poietis, whose mission is to develop and market the Next-Gen Bioprinting platform to bring Tissue Engineering therapies to patients. Fabien has an over 20 years experience in the field of Biofabrication. He holds a PhD in Material Science (INSA, 2000) and an Habilitation in Health and Life Sciences (Bordeaux University, 2010). He was appointed Researcher at INSERM, France in 2005, and invited researcher at Harvard University in 2010. Bioprinting pioneer and inventor (with 100+ publications and 13 patents), he left for entrepreneurship via training at HEC-Paris.

Moderator:

William Harley

blank

William is a Ph.D. candidate within the School of Biomedical Engineering at the University of Melbourne. He obtained a certificate 3 in business management and an honors degree in medical biotechnology from the University of New South Wales where he first entered research focusing on biomaterials, stem cells, and nanofabrication processes for tissue regeneration. Currently, his Ph.D. investigates the use of acoustic micromanipulation and 3D bioprinting as tools to pattern and define the cellular microenvironment. William has held roles as a research assistant and a business development consultant, where he currently serves as a community and events manager for 3D Heals and an organizing committee member for the Australian Bioprinting Workshop.

blank

3D Printing in Hospitals

In recent years, many hospitals have started making a shift, from using medical images primarily for diagnostic purposes, to integrating them in patient-specific surgical planning. This has created enormous advantages for hospitals and their patients and is largely supported by the clarifying regulatory landscape, increased governmental support, new public and private initiatives, and the expanding role of the radiologist as an imaging expert. As part of this, an increasing number of hospitals across the world have integrated the practice of 3D printing into their medical care. Hospitals are recognizing the added value it brings to personalized patient care and the countless possibilities that are becoming a reality, in creating better treatment options.

Speakers:

Kerim Genc

blank

Kerim Genc is the Business Development Manager for the Simpleware Product Group at Synopsys.  He joined Simpleware in 2011 and is currently responsible for managing global sales, business development, partnerships and technical marketing content development, with a significant focus on image-based patient specific workflows for 3D Printing and surgical guides/planning.  He received his BS and MS in biomechanics from the University of Calgary and the Pennsylvania State University respectively, and completed his PhD in Biomedical Engineering at Case Western Reserve University, examining countermeasures to and computational models of spaceflight induced bone loss and fracture risk.

Shannon Walters

blank

Shannon Walters is an innovation enabler and workflow-optimization enthusiast. At Stanford 3D and Quantitative Imaging Lab, Shannon works closely with healthcare providers, researchers, and educators to enable effective health visualization. 

Recent innovations are of particular interest to Shannon such as 3D Printing, immersive volumetric visualization, and concise reporting of changes over time. 

Paul Fotheringham

blank

Paul Fotheringham is the founder of 3D LifePrints (3DLP) and is an experienced Technologist, Entrepreneur, and 3D printing expert who focuses on the medical sector. He holds a joint Bachelor of Science degree in Computer & Management Science from the University of Edinburgh. After graduating, he worked in over 10 countries including the US, UK, HK, Japan, and South Korea as an Enterprise Architect for organizations such as the London Stock Exchange, British Petroleum, Accenture and Macquarie Group. In 2012 he took up a post as Chief Technology Officer for a global Micro-finance organization in Kenya where he subsequently started 3DLP initially as a Social Enterprise in order to provide sustainable, affordable and suitable 3D printed prosthetics for developing world amputees. He currently overseas 3DLP’s European operations from Barcelona that provide a variety of innovative medical 3D printing products and services to medical institutions.

Albert Woo

blank

Albert S. Woo, MD, FACS is a board-certified plastic and reconstructive surgeon specializing in craniofacial surgery. This work has led to a particular interest in three dimensional imaging and printing of complex surgical models. He is an Associate Professor of Surgery, Pediatrics and Neurosurgery at The Warren Alpert Medical School of Brown University and serves as the Chief of the Division of Pediatric Plastic Surgery, Director of the Cleft and Craniofacial Center at Hasbro Children’s Hospital, and is the founding Director of the Lifespan 3D Printing Laboratory.

blank

3D Bioprinting for Food

Lately, 3D printing food has become a hot topic, as climate change and the impending water shortage crisis all beckon humanity for alternative more environmental (and healthier) food sources. “Cultured meat”, “cellular agriculture”, “lab-grown meats” are all new popular concepts that are receiving increasing attention. What are the roles of 3D printing in all this? What are the issues entrepreneurs and scientists facing? Who are the influencers, rising startups, regulatory bodies for this emerging field? How is the culinary world receiving the 3D printing concept? 

Speakers:

Avery Parkinson

blank

Avery is the Executive Director of Cellular Agriculture Canada. She has been passionate about cell ag technology for a couple of years now and has held positions at Tufts University, Big Idea Ventures, the Good Food Institute, and the Protein Report where she has worked on creating educational content and resources to grow the industry nationally and worldwide.

Kyle Von Hasseln

blank

Kyle von Hasseln is an American inventor, entrepreneur and adventurer. He graduated Middlebury College with a focus in molecular ecology. He was awarded the Frank Gehry Prize for Best Thesis at the Southern California Institute of Architecture, where he invented and patented the first dehydrated food 3D printer. His startup, Sugar Lab, was acquired by 3D Systems where he led the development of the first NSF certified commercial food 3D printer. In 2020 he founded Culinary Printworks, the first on-demand culinary 3D printing firm, and brought back the retail Sugar Lab brand. Kyle is an avid backcountry skier, surfer, and alpine rock climber.

Roger Kuan

blank

Roger Kuan is a Partner at Haynes and Boone and chair of the Precision Medicine and Digital Health Practice Group, where he counsels companies that are uniquely positioned in the convergence of the life/medical sciences and technology industries on how to successfully navigate the complexities of the intellectual property (IP), data rights and regulatory challenges they encounter.Roger has extensive experience in IP strategy and portfolio management (utility/design patents, trademarks, copyrights, and trade dress), data rights strategy, licensing and technology transactions, freedom-to-operate clearances, enforcement, monetization, IP due diligence, and dispute resolution. His practice is focused in the life sciences sector (e.g., research tools, analytical instrumentation/software, digital therapeutics, medical devices, diagnostics, biomanufacturing equipment, etc.) with an emphasis in emerging technologies such as Precision Medicine (e.g., genomic sequencing platforms, AI/ML, computational genomics/bioinformatics, molecular diagnostics, companion diagnostics, etc.), Digital Health (e.g., mobile apps, clinical decision support, software, digital therapeutics, AI/ML Imaging Diagnostics, wearables, etc.) and 3D printing/bioprinting. Prior to joining Haynes and Boone, Roger served as Director, IP Counsel at a multinational biotechnology company, where he managed a team to support the worldwide IP needs of the company’s life sciences tools, bioproduction/biomanufacturing, molecular diagnostics, and nucleic acid sequencing system/software platforms. Prior to finishing his law degree, he worked in the life sciences industry for several Fortune 500 pharmaceutical, medical device, and chemical companies. He has held professional positions in the R&D, sales, engineering, and regulatory affairs organizations.

Simon Fried

blank

Simon, head of business at MeaTech, grew up around restaurants, has business experience including food retail, FMCG, distilleries and 3D printing. Combined with his academic background in risk, behavioral economics, and behavior change, he’s excited to be playing a part in the cultivated meat transformation.

Moderator:

Dr. Vidya Chamundeswari Narasimhan

 3DHeals Community Manager – San Francisco

blank

Dr. Vidya is currently heading the Biomaterials engineering division at NEW AGE MEATS – Berkeley, California. She received her Ph.D from Nanyang Technological University(NTU), Singapore in 2018. Her research focused on developing bioactive polymeric scaffolds for musculoskeletal tissue regeneration applications.

During her post doctoral fellowship in Singapore, Vidya spearheaded various academia-industrial collaborative projects. At 3DHEALS, she is our Community Manager of San Francisco Bay Area and is also actively involved in STEM mentorship and in tutoring University and Junior college students for various competitive examinations.  

Vidya has been actively involved in research pertaining to sustainability within the agro-food and biomaterials sector, and is passionate about emerging technologies in the field of 3D bioprinting. She hopes to actively share and spread this interest amongst like minded professionals in the field of  regenerative medicine and tissue engineering. Currently Vidya has contributed to a couple of expert column blogs on bone tissue engineering and is the co-instructor of an online course on Bioinks used for Bioprinting available on Udemy!

blank

3D Printing in Orthopedics

In this virtual event focusing on 3D printing in Orthopedics, we feature a panel of international influencers, rising startups, and hot topics to both learn and discuss what innovators and entrepreneurs are experiencing from their personal perspectives, ranging from metal 3D printing, implants, to various other 3D technologies that are related to 3D printing surgical planning tools, such as AR/VR/MR. Through the conversation, we hope to learn more about current industry landscape and trends.

Speakers:

Dr. Alan Dang

blank

Dr. Alan Dang is a board-certified, licensed orthopaedic spine surgeon. He is an HS Clinical Associate Professor at UCSF. Along with his brother, Dr. Alexis Dang, he started the Orthopaedic Rapid Intelligent Fabrication (ORIF) program at UCSF/San Francisco VA and is a founding member of the UCSF Center for Applied 3D+ Technologies. Dr. Dang is also a capstone mentor and member of the selection committee for the UCSF/UC Berkeley Masters in Translational Medicine program.

Brian McLaughlin

blank

Brian is the founder of Amplify Additive. He is passionate about orthopedics and is well-versed in all aspects of advanced manufacturing – from the industry’s leading innovators and product development to commercialization strategies and business trends. Creative and entrepreneurial by nature, Brian’s attention is on identifying opportunities for new business development in existing and emerging orthopedic markets, and in assisting companies looking to leverage AM technology.

Brian and his team at Amplify are focused on advancing Additive Manufacturing for Orthopedics, utilizing GE Additive’s Arcam Electron Beam Melting (EBM) technology for innovative implant solutions across all indications. Brian has experience across all industry lines in the orthopedic market including design & manufacturing for a leading CMO; as a clinical specialist working directly with surgeons; as the VP of Engineering and co-founder of a Foot & Ankle implant company leveraging AM for implants; and now as the leader at Amplify Additive.  Brian has a BS in Biomedical Engineering from the University of Vermont.  

Brian lives in Yarmouth, ME with his wife and two sons. In addition to his passion for the orthopedic market, he enjoys playing and coaching soccer, alpine skiing, cycling, running and occasionally golfing.

Interview with Dr. Alan Dang, co-Founder of PrinterPrezz

Dr. Bruno Gobbato

blank

Dr. Gobbato is an orthopedic surgeon and specialist in the anatomy of shoulders and elbows. He has been a part of 3D printing in medicine and orthopedic models since 2013. Works with mixed reality and Artificial Intelligence. 

Interview with Dr. Bruno Gobbato: 3D Printing Orthopedics

Dr. Richard Hurley

blank

Dr. Richard Hurley is an orthopaedic surgeon with over a decade of experience in medical 3D printing. He is an assistant professor at Dalhousie University in Halifax, Nova Scotia specialising in hip and knee replacement surgery. In 2012 he co-founded Conceptualiz to provide easy to use virtual surgical planning and medical 3D printing software to healthcare providers. He is the director of the in-hospital medical 3D printing lab at the Dartmouth General Hospital. He is also the curator of the 3D Orthopaedic Special Interest Group (3DOS) and was a former computer assisted surgery product manager for DePuy Canada.

Moderator:

Dr. Nathan J. Castro

blank

Dr. Nathan J. Castro is an experienced biomedical researcher and entrepreneur.  He has assisted in the design, testing, regulatory approval and clinical translation of 3D printed medical devices, as well as co-founded Nanochon, Inc.  He is skilled in policy analysis, life sciences, data analysis, and quantitative research with particular interest in clinical translational (bench-to-bedside).  With domestic and international research appointments at well-recognized laboratories, Dr. Castro is always in search of opportunities to leave a positive impact on whomever he has the pleasure of working with.

blank

The Legal Landscape in Healthcare 3D Printing

It is our experience that risk can be mitigated with knowledge. In the upcoming months, we plan to invite legal and regulatory experts to provide foundation knowledge and updates on the legal landscape in healthcare 3D printing. These webinars will focus on critical issues faced by entrepreneurs and startups in the healthcare 3D printing ecosystem, ranging from intellectual property, medical device liability, as well as FDA and CE regulations and guidance, focusing both on biological and non biological devices.

Speakers:

Sean Burke

Sean Burke profile

Sean Burke is partner and vice chair of the products liability trial division at Duane Morris. He is in the firm’s Washington, DC office.  Mr. Burke’s practice focuses on representation of manufacturers of medical devices in products liability cases across the country, including in consolidated multi-plaintiff matters in both federal court and state courts. His experience includes defense of large total joint replacements (hips, knees, ankles, and shoulders) and resurfacings, tissue matrices and patches, fusion plates, and surgical instruments.  He has a particular interest and focus on additive manufacturing, consulting and advising clients on best practices in the early stages of development to reduce risk of products liability exposure.  He has tried medical device cases before juries in both state and federal courts while also handling numerous mediations.  He works closely with scientific experts to advance causation and liability defenses in the areas of biomechanical engineering, toxicology, histology, epidemiology, orthopedic surgery and FDA regulations.

Roger Kuan

blank

Roger Kuan is a Partner at Haynes and Boone and chair of the Precision Medicine and Digital Health Practice Group, where he counsels companies that are uniquely positioned in the convergence of the life/medical sciences and technology industries on how to successfully navigate the complexities of the intellectual property (IP), data rights and regulatory challenges they encounter.Roger has extensive experience in IP strategy and portfolio management (utility/design patents, trademarks, copyrights, and trade dress), data rights strategy, licensing and technology transactions, freedom-to-operate clearances, enforcement, monetization, IP due diligence, and dispute resolution. His practice is focused in the life sciences sector (e.g., research tools, analytical instrumentation/software, digital therapeutics, medical devices, diagnostics, biomanufacturing equipment, etc.) with an emphasis in emerging technologies such as Precision Medicine (e.g., genomic sequencing platforms, AI/ML, computational genomics/bioinformatics, molecular diagnostics, companion diagnostics, etc.), Digital Health (e.g., mobile apps, clinical decision support, software, digital therapeutics, AI/ML Imaging Diagnostics, wearables, etc.) and 3D printing/bioprinting. Prior to joining Haynes and Boone, Roger served as Director, IP Counsel at a multinational biotechnology company, where he managed a team to support the worldwide IP needs of the company’s life sciences tools, bioproduction/biomanufacturing, molecular diagnostics, and nucleic acid sequencing system/software platforms. Prior to finishing his law degree, he worked in the life sciences industry for several Fortune 500 pharmaceutical, medical device, and chemical companies. He has held professional positions in the R&D, sales, engineering, and regulatory affairs organizations.

Dr. Jenny Chen

jenny chen

Dr. Jenny Chen is trained as a neuroradiologist, founder/CEO of 3DHEALS. Her main interests include medical education, 3D printing in the healthcare sector, and artificial intelligence. She is also a current adjunct clinical faculty in the radiology department at Stanford Healthcare.

blank

3D Bioprinting Vasculatures

3D bioprinting vasculatures is perhaps the holy grail of the next industrial revolution in healthcare. Biofabrication and bioprinting of any viable three-dimensional tissue will not be successful unless the vascularization challenge has been solved. Many organizations and talents around the world are actively tackling this challenge, but where are we exactly?

Speakers:

Andrew Hudson

blank

Andrew received his B.Sc. in Materials Science and Engineering (2014) and M.Sc. in Biomedical Engineering (2015) from Carnegie Mellon University. He is currently a Ph.D. student in Adam Feinberg’s Regenerative Biomaterials and Therapeutics Group. The goal of Andrew’s research is to vastly improve the resolution and vascularization in 3D bioprinting to create the next generation of tissue engineered therapies such as cardiac muscle. Andrew is also a Co-Founder of FluidForm, a CMU startup that seeks to spread the FRESH 3D bioprinting technology developed in the Feinberg lab. 

Jordan Miller

blank

Jordan Miller is an Associate Professor of Bioengineering. at Rice University and Co-Founder of Volumetric, a Houston-based startup focused on next-generation biomaterials and biofabrication technologies. Miller received his bachelor’s degree in Biology from MIT in 2003 and earned his Ph.D. in Bioengineering from Rice University in 2008. His primary interests combine synthetic chemistry, 3D printing, microfabrication, and molecular imaging to direct cultured human cells to form more complex organizations of living vessels and tissues for research in regenerative medicine. Precisely engineered in vitro systems at the molecular, micro- and meso-scale are well suited to decouple the relationship between tissue architecture and cell function. These systems are now permitting comprehensive closed-loop design and optimization of large-scale engineered tissues through refinement with computer models of mass transport and assessment of their therapeutic potential in vivo.

Prafulla Chandra

blank

Dr. Prafulla Chandra is an accomplished life science professional with current specialization in regenerative medicine, 3D bioprinting, and cell biology. He has a Ph.D. in Biotechnology from the University of Pune (India), and more than 16 years of combined scientific research experience. His unique combination of skills and experience include research, technology development and intellectual property related to biomedical and regenerative medicine products. Dr. Chandra has been working at the Wake Forest Institute for Regenerative Medicine (WFIRM) since the past 7 years under the mentorship of Dr. Anthony Atala, where his work in 3D bioprinting includes using extrusion and ink-jet based bioprinters for creating live tissues such as cartilage, bone, skin, urethra and many types of polymer scaffolds for tissue regeneration and diagnostic applications such dermal scaffolds, microfluidics-based cell culture and organ-on-a-chip systems. Additionally, adapting synthetic polymers for 3D bioprinting, creating self-expanding polymers, bioink development, stem-cells based therapies and organ-on-a-chip for screening and diagnostic applications are his other projects at WFIRM. In association with the Regenerative Medicine Clinical Center (RMCC) at WFIRM, Dr. Chandra has also worked on clinical translation of regenerative medicine products, which include an oxygen-generating wound dressing and a 3D bioprinted nasal septum cartilage. He was a core team member for validating a 3D bioprinter for clinical manufacturing and also participated in the writing of regulatory documents such as pre-IND and IND for submission to the US FDA. Prior to joining WFIRM, Dr. Chandra had worked at the New Jersey Center for Biomaterials (under the mentorship of Prof. Joachim Kohn, Director, New Jersey Center for Biomaterials, Rutgers University, NJ, USA), where his work included research in the fields of cell-biomaterial interactions, human skin tissue engineering, surface modification of polymers for enhancing cellular response and using synthetic polymer-based nanospheres for enhancing topical delivery of hydrophobic drugs. One of his research here led to the award of a US Patent (Patent No. 8414871) on which he is a co-inventor.

James (Jay) Hoying, Ph.D.

blank

James (Jay) Hoying, Ph.D. is Partner and Chief Scientist of Advanced Solutions Life Sciences (ASLS), a company pioneering solutions in tissue fabrication and biomanufacturing. Prior to joining ASLS, Dr. Hoying was the Chief of the Division of Cardiovascular Therapeutics at the Cardiovascular Innovation Institute (CII) and a Professor in the Department of Physiology at the University of Louisville. He has over 25 years of experience in basic and applied biological sciences research with a focus in tissue biology, tissue vascularization, and the microcirculation. In addition to his numerous published works, Dr. Hoying holds patents related to vascularizing tissues and related cell-based therapies; technologies that have been translated to companies, including start-ups and ASLS. Dr. Hoying is a Fellow of the American Heart Association.

Moderator:

Lehanna N. Sanders, PhD

Business Development Manager, Advanced Solutions Life Sciences

blank

Dr. Lehanna Sanders is a cellular and molecular biologist and has done research within the field of regenerative medicine for 8 years.  She received her Bachelor’s degree in Cellular, Molecular, and Development Biology from Purdue University where she completed an honors thesis project in Biomedical Engineering.  She then completed her PhD at Vanderbilt University where she published work in the area of molecular repair processes following acute cardiac injury.  During her time at Vanderbilt, she served on the Skills Development Committee for the NHLBI Progenitor Cell Biology Consortium, as well as a member of the Board of the Directors for the Life Science Tennessee-Academic Alliance.  She now works in Business Development for Advanced Solutions Life Sciences, where she is continuing to grow the field of regenerative biology through working closely with scientists and engineers to advance innovations in 3D bioprinting and biofabrication.

Point of Care 3D Printing July 15

Point of Care 3D Printing

Point of care 3D printing is becoming one of the biggest attractions in adopting 3D printing in healthcare systems because it demonstrates the ability to decentralize manufacturing personalized medical devices. The medical devices can range from anatomical modeling, implants, to surgical guides based on the latest updates from all over the world. However, for companies interested in expanding markets either locally or regionally, understanding the complex relationships among different players and regulations are critical. In this webinar, we invited an international panel of experts who had both clinical and industrial experiences in point of care 3D printing to have an exciting conversation that we have all been waiting for.

Speakers:

Andrew Woodward

blank

Andrew has been working in medical imaging for 38 years and holds ARRT certifications in Radiography, Computed Tomography and Quality Management. After 30 years of teaching medical imaging, Andrew retired to join the Advanced Medical Imaging Lab (AMIL) at The University of North Carolina Medical Center in 2106. His experience in education, radiography, vascular interventional radiology, cardiac catheterization and computed tomography added a new perspective on how to expand the AMIL’s services.  In 2017, Andrew provided proof of concept 3D printed models to his superiors and suggested that they implement a Point of Care 3D printing program that would be an integral part the image post-processing the AMIL was currently performing. The idea was well received and he began the process of procuring software and 3D printers to start production of models for patient education and surgical planning. Currently, the AMIL utilizes Mimics inPrint™ for creating the model files and the following printers: three Ultimaker S5; one Ultimaker 3 Extended and a Form3.  Andrew has created models for complex pediatric spinal deformities; pediatric congenital heart defects, adult congenital heart disease, maxillofacial reconstruction and numerous orthopedic models for complex surgical cases. He is also involved in variety of research projects investigating the use of 3D printing of models for surgical training.

Martin Herzmann

blank

Martin Herzmann started his medtech career in 1999 at Brainlab and was responsible for preoperative planning software. In 2007 he joined Ziehm Imaging and worked for another eight years as Marketing Director for medical capital equipment. In 2015, he joined the Materialise Medical division as Sales Manager and was responsible for German-speaking installations of planning software and services for medical 3D printing.

Since 2019, Martin Herzmann has been working as Business Development Manager at Kumovis. The company focuses on medical 3D printing with high-performance polymers and biodegradable polymers and launched the R1 3D printer in summer 2019: a system for additive manufacturing exclusively in medical technology. Customers include both hospitals and medical technology companies.

Paul Fotheringham

blank

Paul Fotheringham is the founder of 3D LifePrints (3DLP) and is an experienced Technologist, Entrepreneur, and 3D printing expert who focuses on the medical sector. He holds a joint Bachelor of Science degree in Computer & Management Science from the University of Edinburgh. After graduating, he worked in over 10 countries including the US, UK, HK, Japan, and South Korea as an Enterprise Architect for organizations such as the London Stock Exchange, British Petroleum, Accenture and Macquarie Group. In 2012 he took up a post as Chief Technology Officer for a global Micro-finance organization in Kenya where he subsequently started 3DLP initially as a Social Enterprise in order to provide sustainable, affordable and suitable 3D printed prosthetics for developing world amputees. He currently overseas 3DLP’s European operations from Barcelona that provide a variety of innovative medical 3D printing products and services to medical institutions.

Daniel Crawford

blank

Daniel Crawford is the Founder & Chief Strategy Officer of axial3D, a company creating automated solutions to make patient specific surgery routine practice in hospitals globally. Daniel graduated with a BSc Hons in Biomedical Engineering and an MSc in Medical Visualisation and Human Anatomy. He has over 10 years experience in medical device development and deployment into clinical settings, 7 of which are specifically related to medical 3D printing and automated applications. Daniel is responsible for the strategy within Axial3D, including its machine learning algorithms for use in creating 3D printed models from 2D medical scans.

Moderator:

Hannah Riedle

blank

Hannah studied Mechanical Engineer at the Technical University of Munich, where she specialized in medical technology. During her following Ph.D. at the Friedrich-Alexander-University Erlangen-Nuremberg, her research focused on the creation of digital anatomical models, additive manufacturing thereof, and as well as biomechanical and medical testing. From the topic of her Ph.D., she derived a business model which resulted in the foundation of ANAMOS in July 2020, where she is now responsible for the operational business as well as the technical development. Hannah has been the Munich-based 3DHEALS community manager since June 2017.